<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Tumors of female reproductive system</journal-id><journal-title-group><journal-title xml:lang="en">Tumors of female reproductive system</journal-title><trans-title-group xml:lang="ru"><trans-title>Опухоли женской репродуктивной системы</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1994-4098</issn><issn publication-format="electronic">1999-8627</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">966</article-id><article-id pub-id-type="doi">10.17650/1994-4098-2022-18-2-21-28</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>MAMMOLOGY. ORIGINAL ARTICLE</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>МАММОЛОГИЯ. ОРИГИНАЛЬНАЯ СТАТЬЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">The influence of the psycho-emotional state of young patients with breast cancer on metastasis after reconstructive plastic surgery</article-title><trans-title-group xml:lang="ru"><trans-title>Влияние психоэмоционального состояния молодых пациенток с онкопатологией молочной железы на метастазирование после реконструктивно-пластических операций</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6134-8719</contrib-id><name-alternatives><name xml:lang="en"><surname>Karasev</surname><given-names>V. E.</given-names></name><name xml:lang="ru"><surname>Карасев</surname><given-names>В. Е.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Department of Oncology with a Course of Radiation Therapy, 12 Lenina St., Omsk 644099;</p><p>9 build. 1 Zavertyaeva St., Omsk 644013</p></bio><bio xml:lang="ru"><p>Кафедра онкологии с курсом лучевой терапии, 644099 Омск, ул. Ленина, 12;</p><p>644013 Омск, ул. Завертяева, 9, корп. 1</p></bio><email>kobra919@yandex.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4205-6507</contrib-id><name-alternatives><name xml:lang="en"><surname>Ismagilov</surname><given-names>A. Kh.</given-names></name><name xml:lang="ru"><surname>Исмагилов</surname><given-names>А. Х.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>11 Mushtari St., Kazan 420012</p></bio><bio xml:lang="ru"><p>420012 Казань, ул. Муштари, 11</p></bio><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Omsk State Medical University</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Омский государственный медицинский университет» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Clinical Oncology Dispensary</institution></aff><aff><institution xml:lang="ru">БУЗОО «Клинический онкологический диспансер»</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Kazan State Medical Academy, a branch of the Russian Medical Academy of Postgraduate Education</institution></aff><aff><institution xml:lang="ru">Казанская государственная медицинская академия – филиал ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2022-09-19" publication-format="electronic"><day>19</day><month>09</month><year>2022</year></pub-date><volume>18</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>21</fpage><lpage>28</lpage><history><date date-type="received" iso-8601-date="2022-09-16"><day>16</day><month>09</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-09-16"><day>16</day><month>09</month><year>2022</year></date></history><permissions><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://ojrs.abvpress.ru/ojrs/article/view/966">https://ojrs.abvpress.ru/ojrs/article/view/966</self-uri><abstract xml:lang="en"><p>To identify the features of breast cancer metastases and assess stress after reconstructive operations, young patients were examined, surveyed for HADS and determined cortisol levels. It has been shown that the appearance of metastases can be influenced by the level of anxiety and depression. Performing breast reconstruction operations by improving the psycho-emotional state reduces the risk of metastasis. </p></abstract><trans-abstract xml:lang="ru"><p>Для выявления особенностей метастазов рака молочной железы и оценки стресса после реконструктивных операций у молодых пациенток проводили обследование, анкетирование по HADS и определение уровня кортизола. Показано, что на появление метастазов может влиять уровень тревоги и депрессии. Проведение операций по реконструкции молочной железы за счет улучшения психоэмоционального состояния снижает риск метастазирования. </p></trans-abstract><kwd-group xml:lang="en"><kwd>metastases</kwd><kwd>breast cancer</kwd><kwd>breast reconstruction surgery</kwd><kwd>mammoplasty</kwd><kwd>anxiety</kwd><kwd>depression</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>метастазы</kwd><kwd>рак молочной железы</kwd><kwd>реконструкция молочной железы</kwd><kwd>маммопластика</kwd><kwd>тревога</kwd><kwd>депрессия</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Drzhevetskaya K.S. Overview of approaches to mass breast cancer screening in Russia and the world. Rossiyskiy elektronnyy zhurnal luchevoy diagnostiki = Russian Electronic Journal of Radiation Diagnostics 2020;10(4):225–36. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Држевецкая К.С. Обзор подходов к массовому скринингу рака молочной железы в России и мире. Российский электронный журнал лучевой диагностики 2020;10(4):225–36.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Vashchenko L.N., Bakulina S.M., Chernikova E.N., Teternikov A.V. Modern possibilities of treating metastatic breast cancer. Mezhdunarodnyy zhurnal prikladnyh i fundamentalnyh issledovaniy = International Journal of Applied and Basic Research 2018;4:165–70. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Ващенко Л.Н., Бакулина С.М., Черникова Е.Н., Тетерников А.В. Современные возможности лечения метастатического рака молочной железы. Международный журнал прикладных и фундаментальных исследований 2018;4:165–70.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><mixed-citation>Yousefi M., Nosrati R., Salmaninejad A. et al. Organ-specific metastasis of breast cancer: molecular and cellular mechanisms underlying lung metastasis. Cell Oncol (Dordr) 2018;41(2):123–40. DOI: 10.1007/s13402-018-0376-6.</mixed-citation></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Cheburkayeva M.Yu., Zakharova N.B., Fedorov V.E. et al. Diagnostic value of bio-markers in the prognosis of postoperative relapses and metastases in patients with breast cancer. Saratov Saratovskiy nauchno-medicinskiy zhurnal = Journal of Medical Scientific Research 2017;13(2):239–44. (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Чебуркаева М.Ю., Захарова Н.Б., Федоров В.Э. и др. Диагностическое значение биомаркеров в прогнозе послеоперационных рецидивов и метастазов у больных раком молочной железы. Саратовский научно-медицинский журнал 2017;13(2):239–44.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><mixed-citation>Liang Y., Zhang H., Song X., Yang Q. Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets. Semin Cancer Biol 2020;60:14–27. DOI: 10.1016/j.semcancer.2019.08.012.</mixed-citation></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Abiltaeva A.A., Adylhanov T.A., Myssayev A.O. Molecular type of breast cancer as prognostic factor for metastasis (literature review). Nauka i zdravookhranenie = Science and Healthcare 2016;(4):119–28. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Абильтаева А.А., Адылханов Т.А., Мысаев А.О. Молекулярный тип рака молочной железы, как прогностический фактор метастазирования (обзор литературы). Наука и здравоохранение 2016;(4):119–28.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><mixed-citation>Sun Y.S., Zhao Z., Yang Z.N. et al. Risk factors and preventions of breast cancer. Int J Biol Sci 2017;13(11):1387–97. DOI: 10.7150/ijbs.21635.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Fidler M.M., Gupta S., Soerjomataram I. et al. Cancer incidence and mortality among young adults aged 20-39 years worldwide in 2012: a population-based study. Lancet Oncol 2017;18:1579–89. DOI: 10.1016/s1470-2045(17)30677-0.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Dai S., Mo Y., Wang Y. et al. Chronic stress promotes cancer development. Front Oncol 2020;10:1492. DOI: 10.3389/fonc.2020.01492.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Xu X.R., Xiao Q., Hong Y.C. et al. Activation of dopaminergic VTA inputs to the mPFC ameliorates chronic stressinduced breast tumor progression. CNS Neurosci Ther 2021;27(2):206–19. DOI: 10.1111/cns.13465.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Krizanova O., Babula P., Pacak K. Stress, catecholaminergic system and cancer. Stress 2016;19:419–28. DOI: 10.1080/10253890.2016.1203415.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Zhang L., Pan J., Chen W. et al. Chronic stress-induced immune dysregulation in cancer: implications for initiation, progression, metastasis, and treatment. Am J Cancer Res 2020;10(5):1294–307.</mixed-citation></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Zhogina Zh.A., Musabayeva L.I., Slonimskaya E.M. Influence of clinical morphological factors on prognosis of early breast cancer. Sibirskiy onkologicheskiy zhurnal = Siberian Journal of Oncology 2003. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Жогина Ж.А., Мусабаева Л.И., Слонимская Е.М. Влияние клинико-морфологических факторов на течение и прогноз ранних форм рака молочной железы. Сибирский онкологический журнал 2003.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><mixed-citation>Cui B., Peng F., Lu J. et al. Cancer and stress: NextGen strategies. Brain Behav Immun 2021;93:368–83. DOI: 10.1016/j.bbi.2020.11.005.</mixed-citation></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Bildanova V.R., Biserova G.K., Shagivaleeva G.R. Psychology of stress and methods of its prevention: educational and methodological manual. Elabuga: EU KFU, 2015. P. 142. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Бильданова В.Р., Бисерова Г.К., Шагивалеева Г.Р. Психология стресса и методы его профилактики: учебно-методическое пособие. Елабуга: ЕИ КФУ, 2015. C. 142.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><mixed-citation>Gosain R., Gage-Bouchard E., Ambrosone C. et al. Stress reduction strategies in breast cancer: review of pharmacologic and non-pharmacologic based strategies. Semin Immunopathol 2020;42(6):719–34. DOI: 10.1007/s00281-020-00815-y.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Meirow Y. Baniyash M. Immune biomarkers for chronic inflammation related complications in non-cancerous and cancerous diseases. Cancer Immunol Immunother 2017;66:1089–101. DOI: 10.1007/s00262-017-2035-6.</mixed-citation></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Oleinikova I.N. Gens G.P., Shikina V.E., Firsov K.A. Influence of the sympathetic nervous system on carcinogenesis (on the example of studies of tumors of the female reproductive system). Onkoginekologiya = Oncogynecology 2020;1(33):16–22. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Олейникова И.Н., Генс Г.П., Шикина В.Е., Фирсов К.А. Влияние симпатической нервной системы на канцерогенез (на примере исследований опухолей органов женской репродуктивной системы). Онкогинекология 2020;1(33):16–22.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">Khaylenko D.V., Egorov Yu.S., Portnoy S.M., Khaylenko V.A. Single-minute reconstructive-plastic operations in nodal forms of stage III breast cancer. Rossiyskiy onkologicheskiy zhurnal = Russian Oncology Journal 2016;21(4):175–8. (In Russ.). DOI: 10.18821/1028-9984- 2016-21-4-175-178.</mixed-citation><mixed-citation xml:lang="ru">Хайленко Д.В., Егоров Ю.С., Портной С.М., Хайленко В.А. Одномоментные реконструктивно-пластические операции при узловых формах рака молочной железы III стадии. Российский онкологический журнал 2016;21(4):175–8. DOI: 10.18821/1028-9984-2016-21-4-175-178.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><mixed-citation>Ng C.G., Mohamed S., Kaur K. et al. Perceived distress and its association with depression and anxiety in breast cancer patients. PLoS One 2017;12(3): e0172975. DOI: 10.1371/journal.pone.0172975.</mixed-citation></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">Tkachenko G.A., Grushina T.I. Interaction of medical psychologist and physiotherapist in stage rehabilitation of breast cancer patients. Palliativnaya medicina i reabilitaciya = Palliative Medicine and Rehabilitation 2018;(3):15–7. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Ткаченко Г.А., Грушина Т.И. Взаимодействие медицинского психолога и физиотерапевта при этапной реабилитации больных раком молочной железы. Паллиативная медицина и реабилитация 2018;(3):15–7.</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><mixed-citation>Brown L.C., Murphy A.R., Lalonde C.S. et al. Posttraumatic stress disorder and breast cancer: Risk factors and the role of inflammation and endocrine function. Cancer 2020;126(14):3181–91. DOI: 10.1002/cncr.32934.</mixed-citation></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">Romanenkov N.S. Clinical and morphological guidelines for breast reconstruction after mastectomy for cancer. Vestnik Dagestanskoy gosudarstvennoy medicinskoy akademii = Bulletin of the Dagestan State Medical Academy 2019;4(33):26–33. (In Russ.).</mixed-citation><mixed-citation xml:lang="ru">Романенков Н.С. Клинико-морфологические ориентиры осуществления реконструкции груди после мастэктомии по поводу рака. Вестник Дагестанской государственной медицинской академии 2019;4(33):26–33.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
